离岸价格
Get Latest Price|
- Minimum Order
国:
Turkey
モデル番号:
-
离岸价格:
ロケーション:
-
最低注文量の価格:
-
最低注文量:
-
パッケージの詳細:
-
納期:
-
供給能力:
-
支払いタイプ:
-
製品グループ :
-
Turkey
連絡先担当者 Taisa
Giyim Kent 19/57A, Istanbul, Esenler
Venclyxto in combination with obinutuzumab is indicated for the
treatment of adult patients with previously untreated chronic
lymphocytic leukaemia (CLL).
Venclyxto in combination with
rituximab is indicated for the treatment of adult patients with
CLL who have received at least one prior therapy.
Venclyxto monotherapy is
indicated for the treatment of CLL:
• in the presence of *7p deletion
or TP*3 mutation in adult patients who are
unsuitable for or have failed a B-cell receptor pathway
inhibitor,
• in the absence of *7p deletion
or TP*3 mutation in adult patients who have
failed both chemoimmunotherapy and a B-cell receptor pathway
inhibitor.
| 国: | Turkey |
| モデル番号: | - |
| 离岸价格: | Get Latest Price |
| ロケーション: | - |
| 最低注文量の価格: | - |
| 最低注文量: | - |
| パッケージの詳細: | - |
| 納期: | - |
| 供給能力: | - |
| 支払いタイプ: | - |
| 製品グループ : | - |
